scorecardresearch
Thursday, April 25, 2024
TopicPharmaceutical companies

Topic: Pharmaceutical companies

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Indian pharma market can more than treble by 2030, says industry report, urges focus on quality

Report by Organisation of Pharmaceutical Producers of India and Ernst & Young says growth could be propelled by expansion in the domestic market, spurred by India's economic growth.

2 cough syrups found ‘contaminated’, regulator launches probe into Gujarat drugmaker

CDSCO says two cough syrups manufactured by Ankleshwar-based Norris Pharma were found to contain Ethylene Glycol (EG) & Diethylene Glycol (DEG) beyond acceptable limits.

Patients’ groups oppose changes to patent rules, say could hinder access to affordable medicines

The groups say Draft Patents (Amendment) Rules could make it harder to challenge patent applications, impede process of obtaining compulsory licences & effect transparency in system.

After small firms, India’s drug regulator puts big companies supplying to US, EU under scanner

Exercise by Central Drugs Standard Control Organisation began as crackdown on small & medium drugmakers, but is being expanded to include major firms after complaints over quality control.

Indore firm linked to cough syrup deaths in Cameroon told to halt manufacture, govt tells Parliament

Naturcold, cough syrup supplied by Riemann Labs, was linked to deaths of 12 kids in Cameroon in March. This is 1st admission by govt of action taken in matter which was flagged by WHO.

Regulatory actions taken against 105 pharma companies, says health minister Mansukh Mandaviya

The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas.

WHO says 20 ‘contaminated’ drugs from Indian & Indonesian makers under scanner

WHO spokesperson says instances of contaminated drugs being found in 6 countries warranted Medical Product Alerts & that it takes reports of substandard medical products seriously.

Glenmark slashes price of HER2-positive breast cancer drug Trumab by 70%, making it cheapest in India

Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.

Govt cancels licence of 18 pharma companies in big crackdown on spurious medicines

The decision was taken by the drugs controller following inspections on 76 companies across 20 states, news agency ANI quoted official sources.

On Camera

BJP has a problem of plenty in Phase 2. It can only go down from that

BJP’s fate in the second phase of 2024 Lok Sabha election will be decided in Karnataka, Rajasthan, and Maharashtra, where it performed very well in 2019 but faces a stiff competition now.

Kotak Mahindra Bank shares drop 10% after RBI bans it from taking new customers via digital channels

The private lender's shares tumbled to be top Nifty 50 loser after India's central bank barred it from taking on new customers through online and mobile banking channels.

Rafale to Exercise Garuda, a look at Indo-French defence ties as Chief of Defence Staff visits France

Another addition to military cooperation has been the Strategic Space Dialogue, inaugurated in Paris in 2023. Last month, India participated as an observer to France’s AsterX.

These 6 states are key for Modi’s ‘400 paar’ target. They’re also where Opposition can stop him

While this contest looks so predictable in large swathes of our political landscape, it is also more keenly contested than 2019 in some states.